GT Biopharma Inc (GTBP)

[trader993]

http://ir.oxis.com/

"OXIS is a biotech company that develops and commercializes innovative drugs of therapeutic molecules including cannabinoids, which are focused on several cancer indications. Oxis address the clinical shortcomings of existing commercial products in related fields. OXIS has formed relationships with some of the world's leading cannabinoid researchers and institutions to advance its technologies."

This was filed with the SEC for example:

"In addition to the company’s current focus, a complimentary business opportunity has emerged in the form of cannabinoids and their impact on several types of diseases.

Oxis Biotech, a wholly owned subsidiary, will address this specific sector.
Oxis Biotech is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from our
intended proprietary cannabinoid product platform in a broad range of disease areas.
We intend to develop CBD therapeutics through proven
drug discovery and development processes, creating an intellectual property portfolio and utilizing our regulatory and manufacturing
expertise. Our CBD program is intended to support the submission of a New Drug Application, or NDA, in cancer-related indications with
the U.S. Food and Drug Administration, or FDA, and in other markets around the world. We plan to develop a deep pipeline of cannabinoid
product candidates and seek patents available to us from several sources including the NIH"

CFO worked for GBLX, a cannabis company. I guess they have plans in this sector. Would be good if there is an update about the progress.